Milene Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Milene Fernandes has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Jorge Nicola
Mayo Clinic, Rochester, Minnesota
4 shared publications - Paulo Nogueira
Nursing Research Innovation and Development Centre of Lisbon (CIDNUR), School of Nursing Universidade de Lisboa Lisbon Portugal
3 shared publications - Andreia Leite
Public Health Research Centre, Comprehensive Health Research Center, CHRC, REAL, CCAL, NOVA University Lisbon National School of Public Health, Lisbon, Portugal
2 shared publications Maria Basto
University of Lisbon
2 shared publications- Miguel de Araújo Nobre
Research, Development and Education Department, MALO CLINIC, Avenida dos Combatentes, 43, Level 11, 1600-042 Lisboa, Portugal
2 shared publications Nuno Vieira
Centro Hospitalar do Barlavento Algarvio
2 shared publications
Latest Publications
- Open Access
- 13 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1199
Artificial Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure: Systematic Review and Meta-Analysis
OBJECTIVES: To systematically review the safety and efficacy of nonbiological (NBAL) or biological artificial liver support systems (BAL) and whole-organ extracorporeal liver perfusion (W-ECLP) systems, in adults with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). DATA SOURCES: Eligible NBAL/BAL studies from PubMed/Embase searches were randomized controlled trials (RCTs) in adult patients with ALF/ACLF, greater than or equal to ten patients per group, reporting outcomes related to survival, adverse events, transplantation rate, and hepatic encephalopathy, and published in English from January 2000 to July 2023. Separately, we searched for studies evaluating W-ECLP in adult patients with ALF or ACLF published between January1990 and July 2023. STUDY SELECTION AND DATA EXTRACTION: Two researchers independently screened citations for eligibility and, of eligible studies, retrieved data related to study characteristics, patients and interventions, outcomes definition, and intervention effects. The Cochrane Risk of Bias 2 tool and Joanna Briggs Institute checklists were used to assess individual study risk of bias. Meta-analysis of mortality at 28–30 days post-support system initiation and frequency of at least one serious adverse event (SAE) generated pooled risk ratios (RRs), based on random (mortality) or fixed (SAE) effects models. DATA SYNTHESIS: Of 17 trials evaluating NBAL/BAL systems, 11 reported 28–30 days mortality and five reported frequency of at least one SAE. Overall, NBAL/BAL was not statistically associated with mortality at 28–30 days (RR, 0.85; 95% CI, 0.67–1.07; p = 0.169) or frequency of at least one SAE (RR, 1.15; 95% CI, 0.99–1.33; p = 0.059), compared with standard medical treatment. Subgroup results on ALF patients suggest possible benefit for mortality (RR, 0.67; 95% CI, 0.44–1.03; p = 0.069). From six reports of W-ECLP (12 patients), more than half (58%) of severe patients were bridged to transplantation and survived without transmission of porcine retroviruses. CONCLUSIONS: Despite no significant pooled effects of NBAL/BAL devices, the available evidence calls for further research and development of extracorporeal liver support systems, with larger RCTs and optimization of patient selection, perfusion durability, and treatment protocols.
- 13 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1199
Open AccessArtificial Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure: Systematic Review and Meta-Analysis
OBJECTIVES: To systematically review the safety and efficacy of nonbiological (NBAL) or biological artificial liver support systems (BAL) and whole-organ extracorporeal liver perfusion (W-ECLP) systems, in adults with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). DATA SOURCES: Eligible NBAL/BAL studies from PubMed/Embase searches were randomized controlled trials (RCTs) in adult patients with ALF/ACLF, greater than or equal to ten patients per group, reporting outcomes related to survival, adverse events, transplantation rate, and hepatic encephalopathy, and published in English from January 2000 to July 2023. Separately, we searched for studies evaluating W-ECLP in adult patients with ALF or ACLF published between January1990 and July 2023. STUDY SELECTION AND DATA EXTRACTION: Two researchers independently screened citations for eligibility and, of eligible studies, retrieved data related to study characteristics, patients and interventions, outcomes definition, and intervention effects. The Cochrane Risk of Bias 2 tool and Joanna Briggs Institute checklists were used to assess individual study risk of bias. Meta-analysis of mortality at 28–30 days post-support system initiation and frequency of at least one serious adverse event (SAE) generated pooled risk ratios (RRs), based on random (mortality) or fixed (SAE) effects models. DATA SYNTHESIS: Of 17 trials evaluating NBAL/BAL systems, 11 reported 28–30 days mortality and five reported frequency of at least one SAE. Overall, NBAL/BAL was not statistically associated with mortality at 28–30 days (RR, 0.85; 95% CI, 0.67–1.07; p = 0.169) or frequency of at least one SAE (RR, 1.15; 95% CI, 0.99–1.33; p = 0.059), compared with standard medical treatment. Subgroup results on ALF patients suggest possible benefit for mortality (RR, 0.67; 95% CI, 0.44–1.03; p = 0.069). From six reports of W-ECLP (12 patients), more than half (58%) of severe patients were bridged to transplantation and survived without transmission of porcine retroviruses. CONCLUSIONS: Despite no significant pooled effects of NBAL/BAL devices, the available evidence calls for further research and development of extracorporeal liver support systems, with larger RCTs and optimization of patient selection, perfusion durability, and treatment protocols.
- Open Access
- 30 March 2022
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 13, 824919
Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
Guidance about treatment-resistant depression (TRD) in Portugal is very limited, even though depression prevalence is among the highest in European countries. A questionnaire was conducted, followed by two advisory boards with seven Portuguese psychiatry experts, to characterize and discuss MDD and TRD epidemiology, diagnosis, patient journey, treatment options, and unmet clinical needs. Consensus was reached on the main issues. In daily practice, TRD can be defined as moderate to severe MDD episodes with insufficient clinical improvement after two antidepressant treatments, taken in adequate doses and duration. TRD diagnosis and treatment are mostly decided by psychiatrists at public hospitals. Treatment type and duration must be adjusted to characteristics of the patient and the depressive episode, including symptoms, number of previous episodes, comorbidities, and previous treatment response and side effects. The most relevant objectives of TRD treatment are reaching response and remission, prevention of suicide, and improvement of quality of life, functionality, and wellbeing. Regarding pharmacotherapy, antidepressant switch occurs more frequently with non-response, while optimization, combination, and augmentation are considered for patients with partial response. Psychotherapy should be considered in parallel to pharmacological treatment. Brain stimulation techniques are underused. Lifelong treatment is required for recurrent or more chronic TRD episodes, but patient adherence is also poorer in these cases. In Portugal, TRD management is limited by lack of access to specialist care and to many treatment options. These aspects highlight that conventional pharmacotherapy does not lead to remission in many patients and that optimization strategies are frequently necessary to achieve satisfactory treatment outcomes.
- 30 March 2022
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 13, 824919
Open AccessTreatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
Guidance about treatment-resistant depression (TRD) in Portugal is very limited, even though depression prevalence is among the highest in European countries. A questionnaire was conducted, followed by two advisory boards with seven Portuguese psychiatry experts, to characterize and discuss MDD and TRD epidemiology, diagnosis, patient journey, treatment options, and unmet clinical needs. Consensus was reached on the main issues. In daily practice, TRD can be defined as moderate to severe MDD episodes with insufficient clinical improvement after two antidepressant treatments, taken in adequate doses and duration. TRD diagnosis and treatment are mostly decided by psychiatrists at public hospitals. Treatment type and duration must be adjusted to characteristics of the patient and the depressive episode, including symptoms, number of previous episodes, comorbidities, and previous treatment response and side effects. The most relevant objectives of TRD treatment are reaching response and remission, prevention of suicide, and improvement of quality of life, functionality, and wellbeing. Regarding pharmacotherapy, antidepressant switch occurs more frequently with non-response, while optimization, combination, and augmentation are considered for patients with partial response. Psychotherapy should be considered in parallel to pharmacological treatment. Brain stimulation techniques are underused. Lifelong treatment is required for recurrent or more chronic TRD episodes, but patient adherence is also poorer in these cases. In Portugal, TRD management is limited by lack of access to specialist care and to many treatment options. These aspects highlight that conventional pharmacotherapy does not lead to remission in many patients and that optimization strategies are frequently necessary to achieve satisfactory treatment outcomes.
- 22 November 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 39 (2) , 241-248
Discontinuation of chronic benzodiazepine use in primary care: a nonrandomized intervention
Chronic benzodiazepine use is a challenge in primary care practice. Protocols to support safe discontinuation are still needed, especially in countries with high utilization rates. To evaluate the feasibility, effectiveness, and safety of a benzodiazepine discontinuation protocol in primary care setting. Nonrandomized, single-arm interventional study, at primary care units. Family physicians (FPs) recruited patients (18–85 years-old) with benzodiazepine dependence and chronic daily use ≥3 months. Patients with daily dosages ≥30 mg diazepam-equivalent, taking zolpidem, with a history of other substance abuse or major psychiatric disease were excluded. After the switch to diazepam, the dosage was gradually tapered according to a standardized protocol. Primary endpoint was the percentage of patients who stopped benzodiazepine at the intervention last visit. Dosage reduction, withdrawal symptoms, patients’ and FPs’ satisfaction with the protocol were evaluated. From 66 enrolled patients (74% female; 66.7% aged >64 years; median time of benzodiazepine use was 120 months), 2 withdrew due to medical reasons and 3 presented protocol deviations. Overall, 59.4% of participants successfully stopped benzodiazepine (60.7% when excluding protocol deviations). Men had higher probability of success (relative risk = 0.51, P = 0.001). A total of 31 patients reported at least 1 withdrawal symptom, most frequently insomnia and anxiety. Most of participating FP considered the clinical protocol useful and feasible in daily practice. Among patients completing the protocol, 77% were satisfied. For the patients who reduced dosage, 85% kept without benzodiazepines after 12 months. The discontinuation protocol with standardized dosage reduction was feasible at primary care and showed long-term effectiveness.
- 22 November 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 39 (2) , 241-248
Discontinuation of chronic benzodiazepine use in primary care: a nonrandomized intervention
Chronic benzodiazepine use is a challenge in primary care practice. Protocols to support safe discontinuation are still needed, especially in countries with high utilization rates. To evaluate the feasibility, effectiveness, and safety of a benzodiazepine discontinuation protocol in primary care setting. Nonrandomized, single-arm interventional study, at primary care units. Family physicians (FPs) recruited patients (18–85 years-old) with benzodiazepine dependence and chronic daily use ≥3 months. Patients with daily dosages ≥30 mg diazepam-equivalent, taking zolpidem, with a history of other substance abuse or major psychiatric disease were excluded. After the switch to diazepam, the dosage was gradually tapered according to a standardized protocol. Primary endpoint was the percentage of patients who stopped benzodiazepine at the intervention last visit. Dosage reduction, withdrawal symptoms, patients’ and FPs’ satisfaction with the protocol were evaluated. From 66 enrolled patients (74% female; 66.7% aged >64 years; median time of benzodiazepine use was 120 months), 2 withdrew due to medical reasons and 3 presented protocol deviations. Overall, 59.4% of participants successfully stopped benzodiazepine (60.7% when excluding protocol deviations). Men had higher probability of success (relative risk = 0.51, P = 0.001). A total of 31 patients reported at least 1 withdrawal symptom, most frequently insomnia and anxiety. Most of participating FP considered the clinical protocol useful and feasible in daily practice. Among patients completing the protocol, 77% were satisfied. For the patients who reduced dosage, 85% kept without benzodiazepines after 12 months. The discontinuation protocol with standardized dosage reduction was feasible at primary care and showed long-term effectiveness.
- 1 July 2018
- Published by Associacao Portuguesa de Medicina Geral e Familiar in Revista Portuguesa de Clínica Geral
- Vol. 34 (4) , 189-199
Utilização de cuidados médicos associados com a tensão arterial em doentes hipertensos: uma análise longitudinal comparando nativos e imigrantes africanos
Introdução: A diversidade étnica e cultural em Portugal tem reforçado a importância de adequar os serviços de saúde às necessidades em saúde de diferentes populações. Este estudo pretende analisar longitudinalmente os fatores associados à utilização de cuidados de saúde em hipertensos tratados portugueses e imigrantes africanos. Métodos: Estudo longitudinal com hipertensos tratados seguidos nos cuidados de saúde primários da região de Lisboa, entre setembro de 2010 e março de 2012. Incluíram-se 233 nativos caucasianos e 170 imigrantes africanos. Aplicaram-se três questionários presencialmente (zero, seis e doze meses) e dois telefonicamente (três e nove meses). O indicador de consumo de recursos foi o número de consultas médicas motivadas pela hipertensão nos três meses anteriores à entrevista. Para a identificação dos fatores estimou-se um modelo longitudinal linear generalizado misto por grupo. Resultados: Mais nativos do que imigrantes consultaram o médico de família no último ano (76,0% vs 64,7%, p=0,019). No entanto, mais imigrantes recorreram a cuidados com caráter de urgência (12,4% vs 5,2%, p=0,016). A proporção de indivíduos que foram ao médico, pelo menos uma vez, não diferiu nos dois grupos (46,5% vs 41,6%, p=0,387). Ajustando para todas as variáveis, a utilização de cuidados médicos pelos nativos revelou estar associada à idade (eβ=1,036; p=0,021), diabetes (eβ=1,898; p=0,006), controlo da hipertensão (OR=1,036; p=0,007), não controlo autopercecionado (eβ=0,596; p=0,033) e tempo de seguimento (eβ=0,771; p=0,001). Nos imigrantes, os fatores significativos foram: estado civil (eβ=2,228; p=0,025), não controlo autopercecionado (eβ=0,580; p=0,013), tempo desde diagnóstico de hipertensão (eβ=1,021; p=0,016) e tempo seguimento (eβ=0,689; p<0,001). Conclusões: Existe a necessidade de compreender melhor as diferenças nos fatores associados à utilização de cuidados de saúde relacionados com a hipertensão, entre nativos e imigrantes, de modo a desenvolver estratégias de promoção da saúde adaptadas às populações-alvo.
- 1 July 2018
- Published by Associacao Portuguesa de Medicina Geral e Familiar in Revista Portuguesa de Clínica Geral
- Vol. 34 (4) , 189-199
Utilização de cuidados médicos associados com a tensão arterial em doentes hipertensos: uma análise longitudinal comparando nativos e imigrantes africanos
Introdução: A diversidade étnica e cultural em Portugal tem reforçado a importância de adequar os serviços de saúde às necessidades em saúde de diferentes populações. Este estudo pretende analisar longitudinalmente os fatores associados à utilização de cuidados de saúde em hipertensos tratados portugueses e imigrantes africanos. Métodos: Estudo longitudinal com hipertensos tratados seguidos nos cuidados de saúde primários da região de Lisboa, entre setembro de 2010 e março de 2012. Incluíram-se 233 nativos caucasianos e 170 imigrantes africanos. Aplicaram-se três questionários presencialmente (zero, seis e doze meses) e dois telefonicamente (três e nove meses). O indicador de consumo de recursos foi o número de consultas médicas motivadas pela hipertensão nos três meses anteriores à entrevista. Para a identificação dos fatores estimou-se um modelo longitudinal linear generalizado misto por grupo. Resultados: Mais nativos do que imigrantes consultaram o médico de família no último ano (76,0% vs 64,7%, p=0,019). No entanto, mais imigrantes recorreram a cuidados com caráter de urgência (12,4% vs 5,2%, p=0,016). A proporção de indivíduos que foram ao médico, pelo menos uma vez, não diferiu nos dois grupos (46,5% vs 41,6%, p=0,387). Ajustando para todas as variáveis, a utilização de cuidados médicos pelos nativos revelou estar associada à idade (eβ=1,036; p=0,021), diabetes (eβ=1,898; p=0,006), controlo da hipertensão (OR=1,036; p=0,007), não controlo autopercecionado (eβ=0,596; p=0,033) e tempo de seguimento (eβ=0,771; p=0,001). Nos imigrantes, os fatores significativos foram: estado civil (eβ=2,228; p=0,025), não controlo autopercecionado (eβ=0,580; p=0,013), tempo desde diagnóstico de hipertensão (eβ=1,021; p=0,016) e tempo seguimento (eβ=0,689; p<0,001). Conclusões: Existe a necessidade de compreender melhor as diferenças nos fatores associados à utilização de cuidados de saúde relacionados com a hipertensão, entre nativos e imigrantes, de modo a desenvolver estratégias de promoção da saúde adaptadas às populações-alvo.
- 30 June 2014
- Vol. 27 (3) , 331-41
[PRAdA intervention: effects on weight of dietary intervention among treated hypertensive Portuguese natives and African immigrants].
Blood pressure is significantly improved with weight loss. Behavioral interventions for weight loss seem to be less successful in African immigrants. Our main aims were to assess the effect of a dietary and lifestyle intervention on weight among hypertensive Portuguese natives and immigrants and to identify success factors for weight loss, and also to evaluate changes in knowledge and compliance with food recommendations. Hypertensive medicated patients followed in primary care setting were randomly enrolled in a two phase study, observational (15-months) and behavioral intervention (six months). Participants were divided in two groups: immigrants from African Countries of Portuguese Official Language and Portuguese natives. Participants were given dietary and life styles recommendations in individual face-to-face and telephone sessions. Of 110 participants with a mean BMI of 31.6 ± 3.7 Kg/m(2), 60 were immigrants. The number of dietary recommendations known and followed at the end was significantly greater than at baseline; however natives performed a greater number of recommendations. Weight loss during intervention was in average 1.4 ± 2.7% in natives and 0.8 ± 3.6% in immigrants and was greater than in the observational period. Being male and consuming more than 2 servings of low-fat dairy products/day was associated with higher weight loss, independently of age and ethnicity. In general the proposed intervention was efficacious especially in Portuguese natives, confirming other studies. The intervention increased knowledge and adherence to recommendations, highlighting the relevance of nutrition education, culturally adapted in primary care.
- 30 June 2014
- Vol. 27 (3) , 331-41
[PRAdA intervention: effects on weight of dietary intervention among treated hypertensive Portuguese natives and African immigrants].
Blood pressure is significantly improved with weight loss. Behavioral interventions for weight loss seem to be less successful in African immigrants. Our main aims were to assess the effect of a dietary and lifestyle intervention on weight among hypertensive Portuguese natives and immigrants and to identify success factors for weight loss, and also to evaluate changes in knowledge and compliance with food recommendations. Hypertensive medicated patients followed in primary care setting were randomly enrolled in a two phase study, observational (15-months) and behavioral intervention (six months). Participants were divided in two groups: immigrants from African Countries of Portuguese Official Language and Portuguese natives. Participants were given dietary and life styles recommendations in individual face-to-face and telephone sessions. Of 110 participants with a mean BMI of 31.6 ± 3.7 Kg/m(2), 60 were immigrants. The number of dietary recommendations known and followed at the end was significantly greater than at baseline; however natives performed a greater number of recommendations. Weight loss during intervention was in average 1.4 ± 2.7% in natives and 0.8 ± 3.6% in immigrants and was greater than in the observational period. Being male and consuming more than 2 servings of low-fat dairy products/day was associated with higher weight loss, independently of age and ethnicity. In general the proposed intervention was efficacious especially in Portuguese natives, confirming other studies. The intervention increased knowledge and adherence to recommendations, highlighting the relevance of nutrition education, culturally adapted in primary care.
- 30 June 2014
- Vol. 27 (3) , 364-71
[Urinary tract infections in a cohort of kidney transplant recipients].
Urinary tract infection is the most common infectious complication following renal transplantation and its frequency is insufficiently studied in Portugal. The aim of this study was to characterize the incidence of urinary tract infections and recurrent urinary tract infections in renal transplant recipients. This was a retrospective cohort observational study, obtained from clinical files of all patients who received a renal transplant at the Hospital of Santa Cruz, from January 2004 to December 2005, with a mean follow-up period of five years or until date of graft loss, death or loss of follow-up. After a descriptive analysis of the population, we used bivariate tests to identify risk factors for urinary tract infections. A total of 127 patients were included, with a 593 patients.year follow-up. We detected 53 patients (41.7%) presenting with at least one episode of urinary tract infection; 21 patients (16.5%) had recurrent urinary tract infection. Female gender was the only risk factor associated with the occurrence of urinary tract infections (p < 0.001, OR = 7.08, RR = 2.95) and recurrent urinary tract infections (p < 0.001, OR = 4.66, RR = 2.83). Escherichia coli (51.6%), Klebsiella pneumoniae (15.5%) and Enterobacter spp (9.9%) were the most frequently identified pathogens. Patients did not reveal an increased mortality or allograft loss. However, urinary tract infections were the most important cause of hospital admissions. Female gender was the only risk factor for urinary tract infections in this population. Escherichia coli was the most frequent agent isolated. Despite preventive measures, urinary tract infections remain an important cause of morbidity and hospital admissions.
- 30 June 2014
- Vol. 27 (3) , 364-71
[Urinary tract infections in a cohort of kidney transplant recipients].
Urinary tract infection is the most common infectious complication following renal transplantation and its frequency is insufficiently studied in Portugal. The aim of this study was to characterize the incidence of urinary tract infections and recurrent urinary tract infections in renal transplant recipients. This was a retrospective cohort observational study, obtained from clinical files of all patients who received a renal transplant at the Hospital of Santa Cruz, from January 2004 to December 2005, with a mean follow-up period of five years or until date of graft loss, death or loss of follow-up. After a descriptive analysis of the population, we used bivariate tests to identify risk factors for urinary tract infections. A total of 127 patients were included, with a 593 patients.year follow-up. We detected 53 patients (41.7%) presenting with at least one episode of urinary tract infection; 21 patients (16.5%) had recurrent urinary tract infection. Female gender was the only risk factor associated with the occurrence of urinary tract infections (p < 0.001, OR = 7.08, RR = 2.95) and recurrent urinary tract infections (p < 0.001, OR = 4.66, RR = 2.83). Escherichia coli (51.6%), Klebsiella pneumoniae (15.5%) and Enterobacter spp (9.9%) were the most frequently identified pathogens. Patients did not reveal an increased mortality or allograft loss. However, urinary tract infections were the most important cause of hospital admissions. Female gender was the only risk factor for urinary tract infections in this population. Escherichia coli was the most frequent agent isolated. Despite preventive measures, urinary tract infections remain an important cause of morbidity and hospital admissions.
- 1 December 2013
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 36 (1) , 212
Erratum to: Non-adherence to antibiotic therapy in patients visiting community pharmacies
- 1 December 2013
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 36 (1) , 212
Erratum to: Non-adherence to antibiotic therapy in patients visiting community pharmacies
- Open Access
- 1 December 2013
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 32 (12) , 957-964
Monitorização à distância versus seguimento convencional presencial em portadores de dispositivos cardíacos implantados: racional e desenho do estudo PORTLink (PORTuguese Research on Telemonitoring with CareLink)
- 1 December 2013
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 32 (12) , 957-964
Open AccessMonitorização à distância versus seguimento convencional presencial em portadores de dispositivos cardíacos implantados: racional e desenho do estudo PORTLink (PORTuguese Research on Telemonitoring with CareLink)
- 8 October 2013
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 36 (1) , 86-91
Non-adherence to antibiotic therapy in patients visiting community pharmacies
Background Patient non-adherence to antibiotic therapy may lead to therapeutic failure, re-infection, and bacterial resistance. Assessing the factors associated with this problem is important for promoting rational use of antibiotics. Objective This study aimed to measure prevalence and reasons for non-adherence to antibiotic treatment and to identify associated factors. Method Patients were recruited for the study in community pharmacies in Lisbon, Portugal, from February to April, 2009. Data from prescriptions for oral antibiotics were collected for adult subjects. Adherence to treatment was assessed with a modified Portuguese version of the Morisky scale. Factors associated with non-adherence were identified through bivariate analysis and logistic regression models. Results A total of 243 patients were included in the study. They had a mean age 46.5 ± 16.6 years and 74.5 % of the sample was female. The prevalence of non-adherence was 57.7 % and was related to delays and failures in taking the prescribed medicine. Increasing age (OR 0.97), difficulty in buying the antibiotic (OR 2.34), duration of treatment (OR 1.28), difficulty with ingestion (OR 3.08), and satisfaction with the information given by physician (OR 0.33) were identified as independent factors associated with non-adherence. Conclusion Non-adherence to antibiotics is common in the community setting. Factors related to the antibiotic, the patient, and the patient-physician relationship should be addressed to promote adherence. Pharmacists should provide information to patients about correct use of antibiotics and address barriers to adherence.
- 8 October 2013
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 36 (1) , 86-91
Non-adherence to antibiotic therapy in patients visiting community pharmacies
Background Patient non-adherence to antibiotic therapy may lead to therapeutic failure, re-infection, and bacterial resistance. Assessing the factors associated with this problem is important for promoting rational use of antibiotics. Objective This study aimed to measure prevalence and reasons for non-adherence to antibiotic treatment and to identify associated factors. Method Patients were recruited for the study in community pharmacies in Lisbon, Portugal, from February to April, 2009. Data from prescriptions for oral antibiotics were collected for adult subjects. Adherence to treatment was assessed with a modified Portuguese version of the Morisky scale. Factors associated with non-adherence were identified through bivariate analysis and logistic regression models. Results A total of 243 patients were included in the study. They had a mean age 46.5 ± 16.6 years and 74.5 % of the sample was female. The prevalence of non-adherence was 57.7 % and was related to delays and failures in taking the prescribed medicine. Increasing age (OR 0.97), difficulty in buying the antibiotic (OR 2.34), duration of treatment (OR 1.28), difficulty with ingestion (OR 3.08), and satisfaction with the information given by physician (OR 0.33) were identified as independent factors associated with non-adherence. Conclusion Non-adherence to antibiotics is common in the community setting. Factors related to the antibiotic, the patient, and the patient-physician relationship should be addressed to promote adherence. Pharmacists should provide information to patients about correct use of antibiotics and address barriers to adherence.